Phathom Pharmaceuticals, Inc. (PHAT)
5.74
-0.48
(-7.72%)
USD |
NASDAQ |
Oct 30, 16:00
5.85
+0.11
(+1.92%)
After-Hours: 20:00
Phathom Pharmaceuticals Profit Margin (Quarterly) : -16.40% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -16.40% |
| June 30, 2026 | -23.67% |
| March 31, 2026 | -52.09% |
| December 31, 2025 | -36.73% |
| September 30, 2025 | -60.55% |
| June 30, 2025 | -191.9% |
| Date | Value |
|---|---|
| March 31, 2025 | -330.7% |
| December 31, 2024 | -251.0% |
| September 30, 2024 | -523.3% |
| June 30, 2024 | -1.25K% |
| March 31, 2024 | -4.33K% |
| December 31, 2023 | -11.67K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Johnson & Johnson | 0.83% |
| Eli Lilly & Co. | 26.44% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -28.09% |
| Return on Invested Capital | -44.27% |
| Gross Profit Margin (Quarterly) | 78.32% |
| Operating Margin (Quarterly) | -0.10% |
| Return on Net Operating Assets | -88.61% |